Rifampin plus isoniazid in initial therapy of pulmonary tuberculosis and rifampin and ethambutol in retreatment cases.
D001663:Bilirubin / Q000097:blood; D003875:Drug Eruptions / Q000209:etiology; D004342:Drug Hypersensitivity / Q000209:etiology; D004977:Ethambutol / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage* / Q000627:therapeutic use; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D012008:Recurrence; D012293:Rifampin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D013183:Sputum / Q000382:microbiology; D000637:Transaminases / Q000097:blood; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology
D004977:Ethambutol; D000637:Transaminases; D001663:Bilirubin; D007538:Isoniazid; D012293:Rifampin